Ghobadi, N., & Asoodeh, A. (2024). Curcumin and Epigallocatechin-3-Gallate: Targeting Receptor Tyrosine Kinases and their Signaling Pathways in Cancer Therapy. Current Pharmacology Reports, 10(6), 297. https://doi.org/10.1007/s40495-024-00379-7
Chicago Style (17th ed.) CitationGhobadi, Niloofar, and Ahmad Asoodeh. "Curcumin and Epigallocatechin-3-Gallate: Targeting Receptor Tyrosine Kinases and Their Signaling Pathways in Cancer Therapy." Current Pharmacology Reports 10, no. 6 (2024): 297. https://doi.org/10.1007/s40495-024-00379-7.
MLA (9th ed.) CitationGhobadi, Niloofar, and Ahmad Asoodeh. "Curcumin and Epigallocatechin-3-Gallate: Targeting Receptor Tyrosine Kinases and Their Signaling Pathways in Cancer Therapy." Current Pharmacology Reports, vol. 10, no. 6, 2024, p. 297, https://doi.org/10.1007/s40495-024-00379-7.